Episode 82 - Heather Turner - CEO LB Pharmaceuticals

We were thrilled to welcome, Heather Turner, CEO of LB Pharmaceuticals, onto The BioHub. Heather is a seasoned biotechnology executive with over 25 years of experience driving legal, operational, and strategic excellence across the biopharmaceutical industry. She currently serves as CEO of LB Pharmaceuticals, a clinical-stage company focused on innovative treatments for schizophrenia. Under her leadership, LB recently went public in a landmark IPO, marking a major milestone in the company’s growth journey.

Prior to LB, Heather led Carmot Therapeutics through a $3.1 billion acquisition by Roche, expanded teams, and executed transformative financing and strategic initiatives. With deep expertise in navigating complex biotech landscapes, Heather’s insights span corporate strategy, IPOs, and driving innovation in clinical-stage development. We’re excited to hear her perspective on leadership, biotech growth, and the future of medicine